Alvotech
Latest news
Investors
04 September 2025
Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
Investors
21 August 2025
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
Investors
20 August 2025
